Skip to main content

Rheumatoid Arthritis

      Residual Pain in RA
      RT @drdavidliew: Treat-to-target in RA is held with an almost religious fervour in rheumatology, but it's really hard to

      David Liew drdavidliew

      3 years 5 months ago
      Treat-to-target in RA is held with an almost religious fervour in rheumatology, but it's really hard to follow religiously. What happens if you're only T2T observant on the high holidays? Answer: the world's not too bad! (2y is bit short I realise) POS0111 #EULAR2022 @RheumNow https://t.co/Boh74JmsP3
      Watch: Treatment of Pre-RA: Is Early Already Too Late?

      Dr. Aurelie Najm reviews abstract OP0070 presented at the #EULAR

      Dr. John Cush RheumNow

      3 years 5 months ago
      Watch: Treatment of Pre-RA: Is Early Already Too Late? Dr. Aurelie Najm reviews abstract OP0070 presented at the #EULAR2022 meeting. #MedEd https://t.co/ep4lgtZYcT https://t.co/LTx1RMGdkv
      RT @ericdeinmd: #EULAR2022 OP0067:
      Depression is a major risk factor (6X!) for mortality in RA. Study may show some bias

      Eric Dein ericdeinmd

      3 years 5 months ago
      #EULAR2022 OP0067: Depression is a major risk factor (6X!) for mortality in RA. Study may show some bias in the methods, but critical findings for all rheumatologists to consider @RheumNow https://t.co/leeY9zAx4T
      No Glory in GLORIA
      RT @ericdeinmd: #EULAR2022
      Ultrasound may be used to evaluate patients with RA (POS1393) and SSc (POS1394)
      👁️Look f

      Eric Dein ericdeinmd

      3 years 5 months ago
      #EULAR2022 Ultrasound may be used to evaluate patients with RA (POS1393) and SSc (POS1394) 👁️Look for B-lines and pleural irregularity Will require training of MSKUS rheumatologists, but another potential application of US in clinical practice @RheumNow @MymaAlbaydaMD @USSONAR_Rh https://t.co/qtnBviKA3w
      Golden Window in Pre-RA
      Watch: EULAR 2022 - Day 1 Faculty Recap Pane

      Drs. Jack Cush, Eric Dein and Kathryn Dao discuss highlights from day 1 at

      Dr. John Cush RheumNow

      3 years 5 months ago
      Watch: EULAR 2022 - Day 1 Faculty Recap Pane Drs. Jack Cush, Eric Dein and Kathryn Dao discuss highlights from day 1 at #EULAR2022 - Guidelines, Lupus, and more. https://t.co/OBLt7dOMa3 https://t.co/lHmEOIFIGa
      A Big Leap in Modulating Rheumatoid Disease

      Intervention in individuals predisposed to develop rheumatoid arthritis (RA

      Dr. John Cush RheumNow

      3 years 5 months ago
      A Big Leap in Modulating Rheumatoid Disease Intervention in individuals predisposed to develop rheumatoid arthritis (RA), with a holy grail of prevention of RA, has long been a hot topic. https://t.co/QHK7c3Qhz6 https://t.co/jFR9wDCD8o
      RT @AurelieRheumo: CTD associated ILD 🫁:
      lncRNA ENST00000604692 detected in PBMCs is associated with CTD-ILD and can

      Aurelie Najm AurelieRheumo

      3 years 5 months ago
      CTD associated ILD 🫁: lncRNA ENST00000604692 detected in PBMCs is associated with CTD-ILD and can distinguish SSc- ILD and RA-ILD vs. non ILD patients with AUC 0.79. As many lncRNA, unknown if biomarker only or has a pathogenic role. @RheumNow OP0114 #EULAR2022 https://t.co/sR4GmaMkXD
      RT @AurelieRheumo: Lung 🫁 cancer incidence and RA

      44000+ RA (EIRA prospective cohort) and 216000+ matched Ctrls Swed

      Aurelie Najm AurelieRheumo

      3 years 5 months ago
      Lung 🫁 cancer incidence and RA 44000+ RA (EIRA prospective cohort) and 216000+ matched Ctrls Swedish registries 📍56 per 100,000 📍HR 1.77 (adjusted for smoking 🚬) 📍Risk in RA + smoking 7x higher 📍Risk 2x in Sero+ vs. sero- No data on ttmt #EULAR2022 @RheumNow POS0061 https://t.co/c7eh3icW2c
      RT @AurelieRheumo: B-cell depletion w/ RTX ttmt is FcγR dependant & affected by FcγRs variants 🧬
      FCGR3A-158V:
      *

      Aurelie Najm AurelieRheumo

      3 years 5 months ago
      B-cell depletion w/ RTX ttmt is FcγR dependant & affected by FcγRs variants 🧬 FCGR3A-158V: *encodes the allotype ⬆️ affinity for IgG1 *is associated w/ clinical and biological responses in RA and SLE. A new way to stratify pts for anti-CD20 therapy? @Yuz6Yusof #EULAR2022 OP0190 https://t.co/GPiaQXaF71
      ×